Hennion & Walsh Asset Management’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.77M Buy
1,847,749
+236,056
+15% +$432K 0.11% 240
2026
Q1
$2.88M Buy
1,611,693
+107,807
+7% +$229K 0.1% 265
2025
Q4
$3.37M Buy
1,503,886
+583,983
+63% +$1.54M 0.12% 230
2025
Q3
$2.23M Sell
919,903
-16,923
-2% -$45K 0.08% 312
2025
Q2
$555K Buy
936,826
+92,549
+11% +$72.1K 0.02% 642
2025
Q1
$740K Buy
844,277
+275,630
+48% +$383K 0.03% 545
2024
Q4
$961K Buy
+568,647
New +$1.03M 0.04% 473

Other funds holding PROK

Hennion & Walsh Asset Management's PROK Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its ProKidney (PROK) stake by 15% in Q2 2026, buying an estimated $432K and bringing the position to 1,847,749 shares worth $3.77M. The position accounts for 0.11% of the portfolio, ranked #240.

Hennion & Walsh Asset Management first reported a position in PROK in Q4 2024 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Hennion & Walsh Asset Management held 1,847,749 shares of ProKidney worth $3.77M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 236,056 ProKidney shares in Q2 2026, an estimated $432K.
  • ProKidney made up 0.11% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #240 holding.
  • Hennion & Walsh Asset Management first reported a position in ProKidney in Q4 2024 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.